Log on / register
Feedback | Support | My details
Spatial preferences of microRNA targets in 3' untranslated regions.
Majoros WH, Ohler U
BMC Genomics 2007, 8:152
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
UTRome.org: a platform for 3'UTR biology in C. elegans.
Mangone M, Macmenamin P, Zegar C, Piano F, Gunsalus KC
Nucleic Acids Res 2008 Jan, 36:D57-62
 [PubMed Central] [PubMed] [Related articles]
2.
Ribonomic analysis of human Pum1 reveals cis-trans conservation across species despite evolution of diverse mRNA target sets.
Morris AR, Mukherjee N, Keene JD
Mol Cell Biol 2008 Jun, 28:4093-103
 [PubMed Central] [PubMed] [Related articles]
3.
Alternative isoform regulation in human tissue transcriptomes.
Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB
Nature 2008 Nov 27, 456:470-6
 [PubMed Central] [PubMed] [Related articles]
4.
Most mammalian mRNAs are conserved targets of microRNAs.
Friedman RC, Farh KK, Burge CB, Bartel DP
Genome Res 2009 Jan, 19:92-105
 [PubMed Central] [PubMed] [Related articles]
5.
A viral microRNA functions as an orthologue of cellular miR-155.
Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR
Nature 2007 Dec 13, 450:1096-9
 [PubMed Central] [PubMed] [Related articles]
6.
A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis.
Ben-Ami O, Pencovich N, Lotem J, Levanon D, Groner Y
Proc Natl Acad Sci U S A 2009 Jan 6, 106:238-43
 [PubMed Central] [PubMed] [Related articles]
7.
Identification of gene 3' ends by automated EST cluster analysis.
Muro EM, Herrington R, Janmohamed S, Frelin C, Andrade-Navarro MA, Iscove NN
Proc Natl Acad Sci U S A 2008 Dec 23, 105:20286-90
 [PubMed Central] [PubMed] [Related articles]
8.
MicroRNA-206: the skeletal muscle-specific myomiR.
McCarthy JJ
Biochim Biophys Acta 2008 Nov, 1779:682-91
 [PubMed Central] [PubMed] [Related articles]
9.
Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development.
Ji Z, Lee JY, Pan Z, Jiang B, Tian B
Proc Natl Acad Sci U S A 2009 Apr 28, 106:7028-33
 [PubMed Central] [PubMed] [Related articles]
10.
The regulatory activity of microRNA* species has substantial influence on microRNA and 3' UTR evolution.
Okamura K, Phillips MD, Tyler DM, Duan H, Chou YT, Lai EC
Nat Struct Mol Biol 2008 Apr, 15:354-63
 [PubMed Central] [PubMed] [Related articles]
11.
MirZ: an integrated microRNA expression atlas and target prediction resource.
Hausser J, Berninger P, Rodak C, Jantscher Y, Wirth S, Zavolan M
Nucleic Acids Res 2009 Jul 1, 37:W266-72
 [PubMed Central] [PubMed] [Related articles]
12.
Coordinated posttranscriptional mRNA population dynamics during T-cell activation.
Mukherjee N, Lager PJ, Friedersdorf MB, Thompson MA, Keene JD
Mol Syst Biol 2009, 5:288
 [PubMed Central] [PubMed] [Related articles]
13.
Probe-level analysis of expression microarrays characterizes isoform-specific degradation during mouse oocyte maturation.
Salisbury J, Hutchison KW, Wigglesworth K, Eppig JJ, Graber JH
PLoS One 2009, 4:e7479
 [PubMed Central] [PubMed] [Related articles]
14.
Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets.
Hausser J, Landthaler M, Jaskiewicz L, Gaidatzis D, Zavolan M
Genome Res 2009 Nov, 19:2009-20
 [PubMed Central] [PubMed] [Related articles]
15.
Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types.
Ji Z, Tian B
PLoS One 2009, 4:e8419
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.